2012-07-03
Probi to launch gut and immune health products in Taiwan with Alvogen
Probi has signed a distribution agreement with Alvogen IPCO S.Á.R.L, a multi-national pharmaceutical company. Alvogen plans to launch Probi’s gut and immune health products on the Taiwanese market in Q1 2013.
